Zydus will be taking over Sterling Biotech's API or Active Pharmaceutical Ingredients Business. Zydus Lifesciences conveyed this information through in exchange filing with the BSE. In the ...

"This right has been exercised by the company," Zydus Lifesciences said in a regulatory filing. The board of directors of the company at their meeting held on September 17, 2024, have approved a ...

Zydus Lifesciences share price gained in the opening trade on September 16 following the company's announcement of a licensing & supply agreement with US-based Viwit Pharmaceuticals. At 09:21am ...

The US health regulator has pulled up Zydus Lifesciences for manufacturing lapses at its Gujarat-based plant. In a warning letter to company's Managing Director Sharvil Patel, the US Food and Drug ...

Zydus Lifesciences Ltd. on Friday announced a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. Viwit has signed the "exclusive licensing and supply agreement" with ...

Zydus Lifesciences Ltd on Friday (September 13) said its wholly-owned subsidiary Zydus Lifesciences Global FZE has entered into an exclusive licensing and supply agreement with Viwit Pharmaceuticals ...

DayQuil Cold & Flu is a multi-purpose medication used to treat common cold and flu symptoms. DayQuil ingredients include a fever and pain reducer (acetaminophen), cough suppressant (dextromethorphan), ...

On August 29, the US Food and Drug Administration (FDA) issued a warning letter to Zydus Lifesciences Ltd.’s medication production facility in Jarod, Gujarat, following an inspection.